[{"NetIncomeLoss_2_Q2_USD":-37542000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":649627000.0,"Liabilities_0_Q2_USD":160496000.0,"HeldToMaturitySecurities_0_Q2_USD":60386000.0,"MarketableSecuritiesCurrent_0_Q2_USD":41280000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":19902000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":10569000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":37299000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":38376000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"GainLossOnSaleOfPropertyPlantEquipment_2_Q2_USD":0.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":3155000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":3053000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":1312810.0,"CurrentFederalTaxExpenseBenefit_2_Q2_USD":-112000.0,"CurrentFederalTaxExpenseBenefit_1_Q2_USD":114000.0,"AssetsCurrent_0_Q2_USD":366994000.0,"DueToRelatedPartiesNoncurrent_0_Q2_USD":67553000.0,"CurrentStateAndLocalTaxExpenseBenefit_2_Q2_USD":-47000.0,"CurrentStateAndLocalTaxExpenseBenefit_1_Q2_USD":47000.0,"DueToRelatedPartiesCurrent_0_Q2_USD":18937000.0,"IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_2_Q2_USD":11000.0,"IncomeTaxesPaidNet_2_Q2_USD":491000.0,"CommonStockSharesIssued_0_Q2_shares":38444580.0,"PaymentsForRepurchaseOfEquity_2_Q2_USD":285000.0,"Assets_0_Q2_USD":379583000.0,"ShareBasedCompensation_2_Q2_USD":7959000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":4762000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":3198000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":129398000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":311472000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2_Q2_pure":0.006,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":28704000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":45418000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":24612000.0,"CapitalLeaseObligationsIncurred_2_Q2_USD":1662000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":-2027000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-385000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":52000.0,"AccountsReceivableNetCurrent_0_Q2_USD":1471000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2_Q2_pure":0.872,"IncomeTaxExpenseBenefit_2_Q2_USD":111000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":62000.0,"CommonStockValue_0_Q2_USD":3959000.0,"Revenues_2_Q2_USD":20729000.0,"Revenues_1_Q2_USD":12379000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":634000.0,"ForeignCurrencyTransactionGainLossBeforeTax_2_Q2_USD":7678000.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q2_USD":-4525000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":152318000.0,"DeferredStateAndLocalIncomeTaxExpenseBenefit_2_Q2_USD":63000.0,"DeferredStateAndLocalIncomeTaxExpenseBenefit_1_Q2_USD":-45000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":28163000.0,"DeferredRevenueNoncurrent_0_Q2_USD":25338000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q2_USD":352800000.0,"OtherAssetsCurrent_0_Q2_USD":1368000.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q2_USD":24529000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":3190000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":147000.0,"OtherAssetsNoncurrent_0_Q2_USD":1483000.0,"DeferredIncomeTaxAssetsNet_0_Q2_USD":140000.0,"CommonStockParOrStatedValuePerShare_0_Q2_EUR":0.09,"InterestReceivableCurrent_0_Q2_USD":7000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":148390000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":2097000.0,"CommonStockSharesOutstanding_0_Q2_shares":38444580.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":24850000.0,"DeferredFederalIncomeTaxExpenseBenefit_2_Q2_USD":207000.0,"DeferredFederalIncomeTaxExpenseBenefit_1_Q2_USD":-54000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-37431000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-27326000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":4559000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":3475000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":-5916000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-4954000.0,"LiabilitiesCurrent_0_Q2_USD":64407000.0,"DeferredRevenueCurrent_0_Q2_USD":13184000.0,"AccountsPayableCurrent_0_Q2_USD":6160000.0,"NonoperatingIncomeExpense_2_Q2_USD":7160000.0,"NonoperatingIncomeExpense_1_Q2_USD":-4524000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":311673000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":10559000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":6728000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":393000.0,"OperatingLeasePayments_2_Q2_USD":863000.0,"OperatingLeasePayments_1_Q2_USD":428000.0,"HeldToMaturitySecuritiesFairValue_0_Q2_USD":60386000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":22000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":3596000.0,"NetIncomeLoss_1_Q2_USD":-27388000.0,"LeaseCost_1_Q2_USD":566000.0,"LeaseCost_2_Q2_USD":1075000.0,"CurrentIncomeTaxExpenseBenefit_1_Q2_USD":161000.0,"CurrentIncomeTaxExpenseBenefit_2_Q2_USD":-159000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":17.42,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":1852000.0,"CommonStockSharesAuthorized_0_Q2_shares":45000000.0,"OperatingIncomeLoss_2_Q2_USD":-44591000.0,"OperatingIncomeLoss_1_Q2_USD":-22802000.0,"DeferredIncomeTaxExpenseBenefit_2_Q2_USD":270000.0,"DeferredIncomeTaxExpenseBenefit_1_Q2_USD":-99000.0,"OperatingLeaseCost_2_Q2_USD":852000.0,"OperatingLeaseCost_1_Q2_USD":434000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":379583000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":2681000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":7959000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":4559000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q2_USD":-23913000.0,"AmortizationOfDebtDiscountPremium_2_Q2_USD":48000.0,"OperatingExpenses_2_Q2_USD":65320000.0,"OperatingExpenses_1_Q2_USD":35181000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":3207000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.01,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.71,"ProfitLoss_2_Q2_USD":-37542000.0,"StockholdersEquity_0_Q2_USD":219087000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":260000.0,"IntangibleAssetsNetIncludingGoodwill_0_Q2_USD":2608000.0,"AccountsReceivableRelatedPartiesCurrent_0_Q2_USD":2212000.0,"VariableLeaseCost_2_Q2_USD":223000.0,"VariableLeaseCost_1_Q2_USD":132000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-437654000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":1597000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2_Q2_USD":-43458000.0,"Ticker":"MRUS","CIK":"1651311","name":"MERUS N.V.","OfficialName":"Merus N.V. Common Shares","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"1055622823.0","Country":"Netherlands","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210805"}]